Day: April 1, 2021

Denver, Colorado, April 01, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”), is pleased to announce the addition of new brands to its CBD products distribution channel.  Legacy Distribution Group, “Legacy Distribution” (Denver, CO) is one of the country’s first CBD-only Direct Store Delivery (DSD) distributors. CBD Global’s Legacy Distribution Group recently welcomed Mad Tasty to its family of CBD brands. Legacy is excited and motivated to build upon Mad Tasty’s significant sales success and help them to fully capture the Colorado market. Brad Wyatt, CEO of CBD Global, shared, “Another addition to the Legacy Distribution family of quality CBD infused beverages.  MAD TASTY has proven to be an innovator in the space and has partnered...

TORONTO, April 01, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) (“Acerus” or the “Company”), a specialty pharmaceutical company focused on the commercialization of novel prescription products in Men’s Health, today announced the signing of an agreement with Aytu BioPharma (f/k/a Aytu BioScience), whereby Acerus bought back all remaining rights to NATESTO in the U.S. that were not already returned to Acerus as part of the 2019 Amended and Restated Agreement with Aytu. Acerus launched promotional efforts to key Urology and Endocrinology specialists in August of 2020. Following early growth in the specialty segment, assuming full ownership of NATESTO fulfills Acerus’ mission to build and leverage a robust commercial business unit in the U.S. Acerus has agreed to purchase these rights from Aytu...

MIAMI, April 01, 2021 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $1.95 on each outstanding share of its Common and Class B common stock payable on April 30, 2021 to shareholders of record at the close of business on April 15, 2021. The Company previously announced in February 2021 that its Board approved a 10% increase in its annual dividend rate to $7.80 per share following 2020’s record operating cash flow. Watsco has paid dividends for 47 consecutive years. The Company’s philosophy is to share increasing amounts of cash flow with shareholders through higher dividends while maintaining a conservative financial position. Future dividends will be considered in light of investment opportunities, cash flow, general economic conditions and the Company’s financial...

BOSTON, April 01, 2021 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc., a rare disease biopharmaceutical company developing novel therapeutics for the treatment of disorders of abnormal mineralization, announced today changes to its scientific advisory board (SAB), including the addition of three leading key opinion leaders with specific expertise in the company’s lead indications:W Charles O’Neill IV, M.D., Director of the Ultrasonography Program in the Renal Division at Emory University School of Medicine Jouni Uitto, M.D., Ph.D., Professor of Dermatology and Cutaneous Biology, and Biochemistry and Molecular Biology, and Chair of the Department of Dermatology and Cutaneous Biology at The Sidney Kimmel Medical College at Thomas Jefferson University, in Philadelphia, Pennsylvania Paul B. Yu, M.D., Ph.D., Section Head of Cardiovascular...

Keskisuomalainen Oyj, tilinpäätös ja toimintakertomus, pörssitiedote, 1.4.2021 klo 14.30 Keskisuomalainen Oyj:n vuosikertomus vuodelta 2020 on julkaistu. Vuosikertomus sisältää hallituksen toimintakertomuksen, tilinpäätöksen, tilintarkastuskertomuksen sekä selvityksen hallinto- ja ohjausjärjestelmästä vuodelta 2020 ja on saatavilla yhtiön verkkosivuilla osoitteessa www.keskisuomalainen.com. Painetun vuosikertomuksen voi tilata yhtiöltä. Keskisuomalainen Oyj:n selvitys muista kuin taloudellisista tiedoista -raportti vuodelta 2020 on julkaistu ja on saatavilla yhtiön verkkosivuilla osoitteessa www.keskisuomalainen.com. Keskisuomalainen Oyj:n palkitsemisraportti vuodelta 2020 on julkaistu ja on saatavilla yhtiön verkkosivuilla osoitteessa www.keskisuomalainen.com. Lisätietoja: Vesa-Pekka Kangaskorpi, toimitusjohtaja, Keskisuomalainen Oyj,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, April 01, 2021 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) announced today it has hired a new Chief Operating Officer (“COO”). Darcy Reding will join the Pieridae team April 5th. Mr. Reding is a professional engineer with 30 years of success in small and mid-sized private and public upstream oil and gas companies, with 20 years in leadership roles. “We are extremely pleased that Darcy has agreed to join our organization,” said Pieridae CEO Alfred Sorensen. ”It is critical we have someone with senior-level experience running complex sour gas assets. Darcy brings us that skill set and is well positioned to take full advantage of the opportunities Pieridae’s assets offer. “We also needed...

ROSELAND, N.J., April 01, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the full year ending December 31, 2020. Arjan Haverhals, President of Milestone Scientific and CEO of Wand Dental Inc., stated, “I am pleased to report that our revenue for the fourth quarter of 2020 increased sequentially by approximately $1 million, or 78% versus the third quarter of 2020. Importantly, we carefully managed our operating expenses during the year and reduced our net loss. We achieved these strong results despite the impact of COVID-19, which shows that we are successfully navigating the pandemic and are on a growth trajectory. Our sales initiatives...

MIAMI, FL, April 01, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s audited 2020 financial performance data, closing the books on a momentous year that featured strong execution in the face of historic obstacles, the establishment of new executive leadership, the successful establishment of new scalable strategies, and tremendous gains in net cash, EBITDA, and topline results, which have helped to drive shareholder value so far in 2021. Read more Financial Highlights for Quarter Ended Dec 31, 2020Consolidated Revenue for the quarter was $10.1 million, representing an increase of 1% compared to Q4 2019. Prescriptions filled during Q4 totaled approximately...

On February 8, 2021, Finantsinspektsioon (FSA) forwarded a decision to Admiral Markets AS notifying the company about an imposed fine. According to the regulator Admiral Markets AS had not acted entirely in accordance with the Securities Market Act, following the crash of Future crude oil prices in April 2020. Admiral Markets AS did not agree with the decision of the FSA and confirmed that it had always acted in the best interests of its clients. The company was confident that regardless of the opinions in the FSA announcement, it operated in accordance with the regulatory framework even when faced with unusual circumstances. Taken all that into concideration, Admiral Markets AS filed an appeal to Harju County Court on 23.02.2021 to challenge the FSA’s decision. According to the Harju County Court order on 31.03.2021, the complaint of...